Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

Havlir, Diane V.; Kendall, Michelle A.; Ive, Prudence; Kumwenda, Johnstone; Swindells, Susan; Qasba, Sarojini S.; Luetkemeyer, Anne F.; Hogg, Evelyn; Rooney, James F.; Wu, Xingye; Hosseinipour, Mina C.; Lalloo, Umesh; Veloso, Valdiléa G.; Some, Fatma F.; Kumarasamy, N.; Padayatchi, Nesri; Santos, Breno R.; Reid, Stewart; Hakim, James; Mohapi, Lerato; Mugyenyi, Peter; Sanchez, Jorge; Lama, Javier R.; Pape, Jean W.; Sanchez, Alejandro; Asmelash, Aida; Moko, Evans; Sawe, Fred; Andersen, Janet; Sanne, Ian; AIDS Clinical Trials Group Study A5221

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

Detalhes bibliográficos
Autor(a) principal:	Havlir, Diane V.
Data de Publicação:	2011
Outros Autores:	Kendall, Michelle A., Ive, Prudence, Kumwenda, Johnstone, Swindells, Susan, Qasba, Sarojini S., Luetkemeyer, Anne F., Hogg, Evelyn, Rooney, James F., Wu, Xingye, Hosseinipour, Mina C., Lalloo, Umesh, Veloso, Valdiléa G., Some, Fatma F., Kumarasamy, N., Padayatchi, Nesri, Santos, Breno R., Reid, Stewart, Hakim, James, Mohapi, Lerato, Mugyenyi, Peter, Sanchez, Jorge, Lama, Javier R., Pape, Jean W., Sanchez, Alejandro, Asmelash, Aida, Moko, Evans, Sawe, Fred, Andersen, Janet, Sanne, Ian, AIDS Clinical Trials Group Study A5221
Tipo de documento:	Artigo
Idioma:	eng
Título da fonte:	Repositório Institucional da FIOCRUZ (ARCA)
DOI:	10.1056/NEJMoa1013607
Texto Completo:	https://www.arca.fiocruz.br/handle/icict/30105
Resumo:	AIDS Clinical Trials Group Study A5221 collaborators: Jones L, Suckow C, Martinez A, Nicotera J, Mensah-King M, Anthony P, Aweeka F, Barlow N, Behm T, Campos P, Firnhaber C, Supparatpinyo K, Leger P, Martinson F, Salata R, Zolopa A, Purcelle E, Smith BA, Near K, DeCarlo E, Mahgoub S, Parker R, Komarow L, Asmuth D, Hanekom W, Walawander A, Corbett A, John MA, van der Horst C, Kondo P, Gutzman H, Hunter H, Pfister S, Poblenz M, Shaw A, Sprenger H, Appiah K.

Metadados do item

id	CRUZ_3f9d0d560af36444d0c2e1441280e9cc
oai_identifier_str	oai:www.arca.fiocruz.br:icict/30105
network_acronym_str	CRUZ
network_name_str	Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str	2135
spelling	Havlir, Diane V.Kendall, Michelle A.Ive, PrudenceKumwenda, JohnstoneSwindells, SusanQasba, Sarojini S.Luetkemeyer, Anne F.Hogg, EvelynRooney, James F.Wu, XingyeHosseinipour, Mina C.Lalloo, UmeshVeloso, Valdiléa G.Some, Fatma F.Kumarasamy, N.Padayatchi, NesriSantos, Breno R.Reid, StewartHakim, JamesMohapi, LeratoMugyenyi, PeterSanchez, JorgeLama, Javier R.Pape, Jean W.Sanchez, AlejandroAsmelash, AidaMoko, EvansSawe, FredAndersen, JanetSanne, IanAIDS Clinical Trials Group Study A52212018-11-19T16:01:46Z2018-11-19T16:01:46Z2011HAVLIR, D. V. et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. New England Journal of Medicine, v. 365, n. 16, p. 1482-1491, 2011.0028-4793https://www.arca.fiocruz.br/handle/icict/3010510.1056/NEJMoa1013607AIDS Clinical Trials Group Study A5221 collaborators: Jones L, Suckow C, Martinez A, Nicotera J, Mensah-King M, Anthony P, Aweeka F, Barlow N, Behm T, Campos P, Firnhaber C, Supparatpinyo K, Leger P, Martinson F, Salata R, Zolopa A, Purcelle E, Smith BA, Near K, DeCarlo E, Mahgoub S, Parker R, Komarow L, Asmuth D, Hanekom W, Walawander A, Corbett A, John MA, van der Horst C, Kondo P, Gutzman H, Hunter H, Pfister S, Poblenz M, Shaw A, Sprenger H, Appiah K.University of San Francisco. San Francisco, CA, USA.Harvard School of Public Health. Boston, MA, USA.University of Witwatersrand. Johannesburg, South Africa.College of Medicine Johns Hopkins Project. Blantyre, Malawi.University of Nebraska. Omaha, NE, USA.National Institutes of Health. Bethesda, MD, USA.University of San Francisco. San Francisco, CA, USA.Social & Scientific Systems. Silver Spring, MD, USA.Gilead Sciences. Foster City, CA, USA.Harvard School of Public Health. Boston, MA, USA.University of North Carolina Project. Kamuzu Central Hospital. Lilongwe, Malawi.University of KwaZulu-Natal. Durban, South Africa.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.Moi University Faculty of Health Sciences. Eldoret, Kenya.YRG Centre for AIDS Research and Education. Voluntary Health Services. Chennai, India.CAPRISA e Thekwini Clinical Research Site. Durban, South Africa.Hospital Nossa Senhora da Conceição. Porto Alegre, RS, Brasil.Centre for Infectious Disease Research in Zambia HIV/AIDS Clinical Trials Unit. Lusaka, Zambia.Parirenyatwa CRS. Harare, Zimbabwe.Chris Hani Baragwanath Hospital ACTG CRS. Soweto, South Africa.Joint Clinical Research Centre. Kampala, Uganda.Asociacion Civil Impacta Salud y Educacion – IMPACTA. Miraflores CRS. Lima, Perú.Investigaciones Medicas en Salud - INMENSA. Lince CRS. Lima, Perú.Les Centres GHESKIO. Port-au-Prince, Haiti.University of Southern California CRS. Los Angeles, CA, USA.Botswana Harvard Aids Institute CRSs. Gaborone and Molepolole, Botswana.Botswana Harvard Aids Institute CRSs. Gaborone and Molepolole, Botswana.Kenya Medical Research Institute./ Walter Reed Project and U.S. Military HIV Research Program. Kericho, Kenya.Harvard School of Public Health. Boston, MA, USA.University of Witwatersrand. Johannesburg, South Africa.Antiretroviral therapy (ART) is indicated during tuberculosis treatment in patients infected with human immunodeficiency virus type 1 (HIV-1), but the timing for the initiation of ART when tuberculosis is diagnosed in patients with various levels of immune compromise is not known.engTiming of antiretroviral therapy for HIV-1 infection and tuberculosisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/30105/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALTiming of Antiretroviral Therapy for HIV-1 Infection_Valdilea_Veloso_INI_Lapclin-AIDS_2011.pdfTiming of Antiretroviral Therapy for HIV-1 Infection_Valdilea_Veloso_INI_Lapclin-AIDS_2011.pdfapplication/pdf622524https://www.arca.fiocruz.br/bitstream/icict/30105/2/Timing%20of%20Antiretroviral%20Therapy%20for%20HIV-1%20Infection_Valdilea_Veloso_INI_Lapclin-AIDS_2011.pdf80cdc37f2294f90e2caa5ba7a49781a6MD52TEXTTiming of Antiretroviral Therapy for HIV-1 Infection_Valdilea_Veloso_INI_Lapclin-AIDS_2011.pdf.txtTiming of Antiretroviral Therapy for HIV-1 Infection_Valdilea_Veloso_INI_Lapclin-AIDS_2011.pdf.txtExtracted texttext/plain42336https://www.arca.fiocruz.br/bitstream/icict/30105/3/Timing%20of%20Antiretroviral%20Therapy%20for%20HIV-1%20Infection_Valdilea_Veloso_INI_Lapclin-AIDS_2011.pdf.txt378cad00230ff5ed7295f8b2b347870cMD53icict/301052023-04-04 12:56:29.66oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-04T15:56:29Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
title	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
spellingShingle	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis Havlir, Diane V.
title_short	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
title_full	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
title_fullStr	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
title_full_unstemmed	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
title_sort	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
author	Havlir, Diane V.
author_facet	Havlir, Diane V. Kendall, Michelle A. Ive, Prudence Kumwenda, Johnstone Swindells, Susan Qasba, Sarojini S. Luetkemeyer, Anne F. Hogg, Evelyn Rooney, James F. Wu, Xingye Hosseinipour, Mina C. Lalloo, Umesh Veloso, Valdiléa G. Some, Fatma F. Kumarasamy, N. Padayatchi, Nesri Santos, Breno R. Reid, Stewart Hakim, James Mohapi, Lerato Mugyenyi, Peter Sanchez, Jorge Lama, Javier R. Pape, Jean W. Sanchez, Alejandro Asmelash, Aida Moko, Evans Sawe, Fred Andersen, Janet Sanne, Ian AIDS Clinical Trials Group Study A5221
author_role	author
author2	Kendall, Michelle A. Ive, Prudence Kumwenda, Johnstone Swindells, Susan Qasba, Sarojini S. Luetkemeyer, Anne F. Hogg, Evelyn Rooney, James F. Wu, Xingye Hosseinipour, Mina C. Lalloo, Umesh Veloso, Valdiléa G. Some, Fatma F. Kumarasamy, N. Padayatchi, Nesri Santos, Breno R. Reid, Stewart Hakim, James Mohapi, Lerato Mugyenyi, Peter Sanchez, Jorge Lama, Javier R. Pape, Jean W. Sanchez, Alejandro Asmelash, Aida Moko, Evans Sawe, Fred Andersen, Janet Sanne, Ian AIDS Clinical Trials Group Study A5221
author2_role	author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author
dc.contributor.author.fl_str_mv	Havlir, Diane V. Kendall, Michelle A. Ive, Prudence Kumwenda, Johnstone Swindells, Susan Qasba, Sarojini S. Luetkemeyer, Anne F. Hogg, Evelyn Rooney, James F. Wu, Xingye Hosseinipour, Mina C. Lalloo, Umesh Veloso, Valdiléa G. Some, Fatma F. Kumarasamy, N. Padayatchi, Nesri Santos, Breno R. Reid, Stewart Hakim, James Mohapi, Lerato Mugyenyi, Peter Sanchez, Jorge Lama, Javier R. Pape, Jean W. Sanchez, Alejandro Asmelash, Aida Moko, Evans Sawe, Fred Andersen, Janet Sanne, Ian AIDS Clinical Trials Group Study A5221
description	AIDS Clinical Trials Group Study A5221 collaborators: Jones L, Suckow C, Martinez A, Nicotera J, Mensah-King M, Anthony P, Aweeka F, Barlow N, Behm T, Campos P, Firnhaber C, Supparatpinyo K, Leger P, Martinson F, Salata R, Zolopa A, Purcelle E, Smith BA, Near K, DeCarlo E, Mahgoub S, Parker R, Komarow L, Asmuth D, Hanekom W, Walawander A, Corbett A, John MA, van der Horst C, Kondo P, Gutzman H, Hunter H, Pfister S, Poblenz M, Shaw A, Sprenger H, Appiah K.
publishDate	2011
dc.date.issued.fl_str_mv	2011
dc.date.accessioned.fl_str_mv	2018-11-19T16:01:46Z
dc.date.available.fl_str_mv	2018-11-19T16:01:46Z
dc.type.status.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv	info:eu-repo/semantics/article
format	article
status_str	publishedVersion
dc.identifier.citation.fl_str_mv	HAVLIR, D. V. et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. New England Journal of Medicine, v. 365, n. 16, p. 1482-1491, 2011.
dc.identifier.uri.fl_str_mv	https://www.arca.fiocruz.br/handle/icict/30105
dc.identifier.issn.pt_BR.fl_str_mv	0028-4793
dc.identifier.doi.none.fl_str_mv	10.1056/NEJMoa1013607
identifier_str_mv	HAVLIR, D. V. et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. New England Journal of Medicine, v. 365, n. 16, p. 1482-1491, 2011. 0028-4793 10.1056/NEJMoa1013607
url	https://www.arca.fiocruz.br/handle/icict/30105
dc.language.iso.fl_str_mv	eng
language	eng
dc.rights.driver.fl_str_mv	info:eu-repo/semantics/openAccess
eu_rights_str_mv	openAccess
dc.source.none.fl_str_mv	reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ
instname_str	Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str	FIOCRUZ
institution	FIOCRUZ
reponame_str	Repositório Institucional da FIOCRUZ (ARCA)
collection	Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv	https://www.arca.fiocruz.br/bitstream/icict/30105/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/30105/2/Timing%20of%20Antiretroviral%20Therapy%20for%20HIV-1%20Infection_Valdilea_Veloso_INI_Lapclin-AIDS_2011.pdf https://www.arca.fiocruz.br/bitstream/icict/30105/3/Timing%20of%20Antiretroviral%20Therapy%20for%20HIV-1%20Infection_Valdilea_Veloso_INI_Lapclin-AIDS_2011.pdf.txt
bitstream.checksum.fl_str_mv	586c046dcfeef936e32f0323bb9a47c0 80cdc37f2294f90e2caa5ba7a49781a6 378cad00230ff5ed7295f8b2b347870c
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5
repository.name.fl_str_mv	Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv	repositorio.arca@fiocruz.br
_version_	1822792129277067264

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

Registros relacionados